FDA authorizes bivalent COVID boosters for younger children
The Food and Drug Administration (FDA) on Wednesday announced it has amended its emergency authorization of the bivalent COVID-19 boosters to include children between the ages of five and 11.
The FDA’s decision grants Moderna’s…